| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.8 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |